Experience of cyclooxygenase inhibitor use for correction of urine overproduction in incontinent women

Cover Page


Hypothesis/aims of study. Questions of urine incontinence pathogenesis and ways of treatment are actively discussed by gynecologists, urologists and neuropathologists. Urine incontinence often has multifactor origin: the causes of urine incontinence are connected, as a rule, with violation of urine continence functional mechanisms, anatomical and topographical features of the lower urinary tract or an age failure of ovaries function. At the same time changes of kidneys function play part in urine incontinence pathogenesis. In some cases urine incontinence is combined with urine overproduction or inversion of circadian rhythm of renal function due to decrease in a reabsorption sodium ions in the thick ascending limb of a Henle’s loop. The reabsorption of Na+, K+, Ca2+, Mg2+, Cl– in this department of a nephron is increased by vasopressin activation of V2-receptors. In some patients we succeeded to normalize ions transport, diuresis, circadian rhythm of urine production by desmopressin administration, however in some cases significant decrease in a diuresis did not happen. The lack of therapy effect could be connected with local production of substances resisting to effect of this hormone, in particular prostaglandin E2. The current analysis was undertaken to evaluate the clinical efficiency of Diclofenac in incontinent patients with nocturnal polyuria and polyuria.

Study design, materials and methods. A total of 44 patients with complaints of urinary incontinence, polyuria (24-urine volume of 40 mL/kg bodyweight or above) or nocturnal polyuria (nocturnal volume/24-h urine volume of 0.33 or above) (Van Kerrebroeck P., 2002) and 14 control subjects were included. Mean patient age was 42.8 ± 4.5 years, in control subjects 39.4 ± 6.3 (p > 0.05). All participants performed 72h-urinecollection to determine the voided volumes and the levels of creatinine, osmolality, sodium, magnesium and potassium for each sample. A blood sample was taken during the 72-urinecollection to determine the levels of creatinine, osmolality, sodium, magnesium and potassium. The examination of patients with polyuria and nocturnal polyuria was performed twice: in the initial state and one month after the start of treatment with optimal dose of Diclofenac.

Results. In patients with polyuria and nocturnal polyuria the glomerular filtration rate was normal, whereas diuresis and solute (sodium, magnesium, potassium) clearance in night samples in nocturnal polyuria and both in night and day samples was higher. Diclofenac use had the normalizing effect on transport of ions in a nephron.

Natalya A. Osipova

St. Petersburg State University

Author for correspondence.
Email: naosipova@mail.ru

Russian Federation, Saint Petersburg

Professor, Assistant PhD, Medical Faculty, Department of Obstetrics, Gynecology and Reproductology

Dariko A. Niauri

St. Petersburg State University

Email: d.niauri@mail.ru

Russian Federation, Saint Petersburg

MD, PhD, DMedSci, Professor, Medical Faculty, Department of Obstetrics, Gynecology and Reproductology

Alexander M. Gzgzyan

St. Petersburg State University

Email: d.niauri@mail.ru

Russian Federation, Saint Petersburg

MD, PhD, DMedSci, Department of Obstetrics, Gynecology and Reproductology

  • Аполихина И.А., Ромих В.В., Андикян В.М. Современные принципы консервативного лечения недержания мочи у женщин // Урология. — 2005. — № 5. — С. 72–75. [Apolikhina IA, Romikh VV, Andikyan VM. Current principles of conservative treatment of urine incontinence in women. Urologiia. 2005;5:72-5. (In Russ.)]
  • Балан В.Е., Анкирская А.С., Есесидзе З.Т., и др. Патогенез атрофического цистоуретрита и различные виды недержания мочи у женщин в климактерии // Consilium medicum. — 2001. — № 3(7). — С. 326–331. [Balan VE, Ankir skaja AS, Esesidze ZT, et al. Patogenezatroficheskogo cistouretrita i razlichnye vidy nederzhanija mochi u zhenshhin v klimakterii. Consilium medicum. 2001;3(7):326-31. (In Russ.)]
  • Неймарк А.И., Раздорская М.В. Актуальные проблемы урогинекологии. Недержание мочи у женщин // Акушерство и гинекология. — 2011. — № 4. — С. 27–34. [Neimark AI, Razdorskaya MV. Topical problems in uro gynaecology. Urinary incontinence in women. Obstetrics and Gynecology. 2011;4:27-34. (In Russ.)]
  • Пушкарь Д.Ю., Щавелева О.Б. Диагностика и результаты лечения смешанных форм недержания мочи у женщин // Урология. — 2005. — № 3. — С. 22–25. [Pushkar’ DJu, Shhaveleva OB. Diagnostika i rezul’taty lechenija smeshannyh form nederzhanija mochi u zhenshhin. Urologiia. 2005;(3):22-5. (In Russ.)]
  • Hampel C, Wienhold D, Benken N, et al. Prevalence and natural history of female incontinence. Eur Urol. 1997;32(Suppl. 2):3-12.
  • Rose A, Thimme A, Halfar C, et al. Severity of urinary incontinence of nursing home residents correlates with malnutrition, dementia and loss of mobility. Urol Int. 2013;91(2):165-9. doi: 10.1159/000348344.
  • Turan C, Gurkan Zorlu C, Murat Ekin, et al. Urinary incontinence in women of reproductive age. Gynecol Obstet Invest . 1996;41:132-4.
  • Jonas U. Introduction and conclusions. Eur Urol. 2005;4(1):1-4.
  • Осипова Н.А., Гулиев Б.Г., Ниаури Д.А., Гзгзян А.М. Осморегулирующая функция почек при различных типах недержания мочи у женщин // Экспериментальная и клиническая урология. — 2016. — № 3. — С. 144–149. [Osipova NA, Guliev BG, Niauri DA, Gzgzjan AM. Osmore gulirujushhaja funkcija pochek pri razlichnyh tipah nederzhanija mochi u zhenshhin. Jeksperimental’naja i kliniche skaja urologija. 2016;3:144-9. (In Russ.)]
  • Осипова Н.А., Ниуари Д.А., Гзгзян А.М. Ионорегулирующая функция почек при различных типах недержания мочи у женщин // Журнал акушерства и женских болезней. — 2016. — № 2. — С. 44–53. [Osipova NA, Niuari DA, Gzgzjan AM. Ion regulatory function of the kidney in incontinent women. Journal of Obstetrics and Women’s Diseases. 2016;(2):44-53 (In Russ.)]. doi: 10.17816/JOWD65244-53.
  • Rouffignac С. Multihormonal regulation of nephron epithelia achieved through combinational mode. Am J Physiol. 1995;269(4):R739-R748.
  • Осипова Н.А., Ниуари Д.А., Гзгзян А.М. Патогенетическое обоснование возможности применения антидиуретического гормона при недержании мочи у женщин // Журнал акушерства и женских болезней. — 2017. — № 4. — С. 68–78. [Osipova NA, Niuari DA, Gzgzjan AM. Pathogenetic justification of possibility of antidiuretic hormone use in incontinent women. Journal of Obstetrics and Women’s Diseases. 2017;(4):68-78. (In Russ.)]. doi: 10.17816/JOWD66468-78.
  • van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the Standardization Subcommittee of the International Continence Society. Neurourol Urodyn. 2000;211:79-83.
  • Борисов И.А., Перов Ю.Л. Старческая почка // Нефрология / И.Е. Тареева, ред. — М., 2001. — С. 509–525. [Bo risov IA, Perov JuL. Starcheskaja pochka. In: Nefrologija. Ed by I.E. Tareeva. Moscow; 2001:509-25. (In Russ.)]
  • Тюзиков И.А., Греков Е.А., Апетов С.С., и др. Ноктурия: современные гендерные аспекты эпидемиологии, патогенеза и диагностики // Экспериментальная и клиническая урология. — 2013. — № 3. — С. 113–122. [Tjuzikov IA, Grekov EA, Apetov SS, et al. Nokturija: sovremennye gendernye aspekty jepidemiologii, patogeneza i diagnostiki. Jeksperimental’naja i klinicheskaja urologija. 2013;(3):113-22. (In Russ.)]
  • Наточин Ю.В. Физиология почки: формулы и расчеты. — Л.: Наука, 1974. [Natochin JuV. Fiziologija pochki: formuly i raschety. Leningrad: Nauka; 1974. (In Russ.)]
  • Jerez-Roig J, Santos MM, Souza DL, et al. Prevalence of urinary incontinence and associated factors in nursing home residents. Neurourol Urodyn. 2016;35(1):102-7. doi: 10.1002/nau.22675.
  • Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-78.
  • Мазо Е.Б. Медикаментозное лечение гиперактивного мочевого пузыря // Русский медицинский журнал. — 2004. — № 12(8). — С. 522–526. [Mazo EB. Medikamentoznoe lechenie giperaktivnogo mochevogo puzyrja. Russkij medicinskij zhurnal. 2004;12(8):522-6. (In Russ.)]
  • Bissada NK. Urologic manifestations of drug therapy. Urol Clin Noth Am. 1988;15:725-36.
  • Sellers DJ, Chapple CR, Chess-Williams R. Potential therapeutic targets for the treatment of the overactive bladder. World J Urol. 2001;19(5):307-11.
  • Wein AJ. Pharmacological agents for the treatment of urinary incontinence due to overactive bladder. Expert Opin Investig Drugs. 2000;10(1):65-83.
  • Han YK., Lee WK, Lee SH, et al. Effect of desmopressin with anticholinergics in female patients with overactive bladder. Korean J Urol. 2011 Jun;52(6):396-400.
  • Hilton P, Stanton SL. The use of Desmopressin in nocturnal urinary frequency in the female. Br J Urol. 1982;54:252-5.
  • Jeong JY, Kim SJ, Cho HJ, et al. Influence of type of nocturia and lower urinary tract symptoms on therapeutic outcome in women treated with desmopressin. Korean J Urol. 2013;54(2):95-9. doi: 10.4111/kju.2013.54.2.95.
  • Lee HW, Choo MS, Lee JG, et al. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. J Korean Med Sci. 2010;25(12):1792-7.
  • Mun JH, Kim SO, Yu HS, et al. Effects of desmopressin for the treatment of nocturnal polyuria in elderly women: impact on related sleep quality. Can Urol Assoc J. 2015;9(11-12):E770-4. doi: 10.5489/cuaj.3097.
  • Robinson D, Cardozo L, Akeson M, et al. Antidiuresis: a new concept in managing female daytime urinary incontinence. BJU Int. 2004;93(7):996-1000. doi: 10,1111/j.1464-410X.2004.04768.x.
  • Тюзиков И.А., Калиниченко С.Ю., Ворслов Л.О., Тишова Ю.А. Дефицит вазопрессина как причина никтурии и гормонально-метаболических нарушений у мужчин. Роль десмопрессина в их коррекции // Эффективная фармакотерапия. — 2015. — № 27. — C. 26–37.[Tjuzikov IA, Kalinichenko SJu, Vorslov LO, Tishova JuA. Vasopressin Deficiency as a Cause of Nocturia and Hormonal-Metabolic Disorders in Men. A Role of Desmopressin in Their Correction. Jeffektivnaja farmakoterapija. 2015;27:26-37. (In Russ.)].
  • Nørgaard JP, Pedersen EB, Djurhuus JC. Diurnal anti-diuretic-hormone levels in enuretics. J Urol. 1985;134(5):1029-31.
  • Rittig S, Knudsen UB, Nørgaard JP, et al. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256(4 Pt 2):F664-71.
  • Осипова Н.А., Ниаури Д.А., Зиятдинова Г.М. Суточный ритм мочеобразования и мочеотделения при недержании мочи у женщин // Гинекология. — 2015. — № 2. — С. 74–76. [Osipova NA, Niauri DA, Zijatdinova GM. Sutochnyj ritm mocheobrazovanija i mocheotdelenija prineder zhanii mochi u zhenshhin. Ginekologija. 2015;(2):74-6. (In Russ.)]
  • Иванова Л.H. Вазопрессин: клеточные и молекулярные аспекты его антидиуретического действия // Вест. РАМН. — 1999. — № 3. — С. 40–45. [Ivanova LH. Vazopressin: kletochnye i molekuljarnye aspekty ego anti diureticheskogo dejstvija. Vest. RAMN. 1999;(3):40-5. (In Russ.)]
  • Sabolic I, Brown D. Water transport in renal tubule is mediated by aquaporins. J Clin Invest. 1994;72(9):698-700.
  • Наточин Ю.В. Физиология водно-солевого обмена и поч ки. — СПб., 1993. [Natochin JuV. Fiziologija vodno-solevogo obmena i pochki. Saint Petersburg; 1993. (In Russ.)]
  • Aarab L, Siaume-Perez S, Chabardès D. Cell-specific coupling of PGE2 to different transduction pathways in arginine vasopressin- and glucagon-sensitive segments of the rat renal tubule. Br J Pharmacol. 1999;126(4):1041-9.
  • Гончаревская О.А., Наточин Ю.В. Простагландин Е2 угнетает реабсорбцию магния в начальном отделе дистального отдела нефрона тритона // Докл. РАН. — 1994. — Т. 337. — № 1. — С. 125–127. [Goncharevskaja OA, Natochin JuV. Prostaglandin E2 ugnetaet reabsorbciju magnija v nachal’nom otdele distal’nogo otdela nefrona tritona. Dokl. RAN. 1994;337(1):125-7. (In Russ.)]
  • Cho KJ, Kim HS, Koh JS, Kim JC. Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics. Int Urogynecol J. 2013;24(2):325-30. doi: 10.1007/s00192-012-1854-4.
  • Kim JC, Park EY, Seo SI, et al. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol. 2006;175(5):1773-6. doi: 10.1016/S0022-5347(05)00992-4.
  • Marentette JO, Hurst RE, McHowat J. Impaired Expression of Prostaglandin E2 (PGE2) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome. PLOS One. 2015;10(6):e0129466. doi: 10.1371/journal.pone.0129466.
  • Danon A, Zenser TV, Thomasson DL, Davis BB. Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. Cancer Res. 1986;46(11):5676-81.
  • Wong YH, Zenser TV, Davis BB. Regulation of dog urothelial cell arachidonic acid release and prostaglandin E2 synthesis. Carcinogenesis. 1989;10(9):1621-7.
  • Delaere KP, Debruyne FM, Moonen WA. The use of indomethacin in the treatment of idiopathic bladder instability. Urol Int. 1981;36(2):124-7.
  • Sprem M, Milicić D, Oresković S, et al. Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study. Croat Med J. 2000;41(4):423-7.
  • Takagi-Matsumoto H, Ng B, Tsukimi Y, Tajimi M. Effects of NSAIDs on bladder function in normal and cystitis rats: a comparison study of aspirin, indomethacin, and ketoprofen. J Pharmacol Sci. 2004;95(4):458-65.

Supplementary files

Supplementary Files Action
1. Fig. 1. Effect of Diclofenac on sodium clearance in polyuria View (19KB) Indexing metadata
2. Fig. 2. Effect of Diclofenac on potassium clearance in polyuria View (21KB) Indexing metadata
3. Fig. 3. Effect of Diclofenac on magnesium clearance in polyuria View (21KB) Indexing metadata
4. Fig. 4. Effect of Diclofenac on sodium clearance in nocturnal polyuria View (24KB) Indexing metadata
5. Fig. 5. Effect of Diclofenac on potassium clearance in nocturnal polyuria View (22KB) Indexing metadata
6. Fig. 6. Effect of Diclofenac on magnesium clearance in nocturnal polyuria View (22KB) Indexing metadata


Abstract - 113

PDF (Russian) - 116


CrossRef     1 citations

  • Osipova NA, Niauri DA, Gzgzyan AM. Clinical efficiency of desmopressin and cyclooxygenase inhibitor use in incontinent women. Journal of obstetrics and women's diseases. 2018;67(2):40. doi: 10.17816/JOWD67240-51


Copyright (c) 2018 Osipova N.A., Niauri D.A., Gzgzyan A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.